That accelerated muscle loss affects metabolic rate, functional strength, bone density, and long-term weight maintenance after stopping the medication
(2) Svensson J, Lall S, Dickson SL, Bengtsson BA, Rmer J, Ahnfelt-Rnne I, Ohlsson C, Jansson JO
No impairment of glucose metabolism
Frequently Asked Questions What does the article's outcomes table give for 52-week average weight loss with each compound
Because interaction of GLP-1 with receptors in the intestine is sufficient to activate all major responses required to impact both diabetes and obesity, it is anticipated that the administration of GLP-1 receptor agonist (GLP-1 RA) in such a way that they pass across intestinal tissue, should be an ideal method for delivering these peptides
The American Diabetes Association emphasizes that successful long-term weight maintenance typically requires ongoing intervention, whether pharmacological, behavioral, or both